Skip to main navigation Skip to search Skip to main content

Long-term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11)

  • Hongsik Kim
  • , Dong Wan Kim
  • , Miso Kim
  • , Youngjoo Lee
  • , Hee Kyung Ahn
  • , Jang Ho Cho
  • , Il Hwan Kim
  • , Yun Gyoo Lee
  • , Seong Hoon Shin
  • , Song Ee Park
  • , Jiyoon Jung
  • , Eun Joo Kang
  • , Myung Ju Ahn*
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Long-term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry